Breaking Research News from Breastcancer.org
Comments
-
One in Six Women Choose Double Mastectomy
January 18, 2016
Nearly half of women diagnosed with early-stage breast cancer considered having a double mastectomy and about 17% had the surgery, including many women who were a low risk of developing a second breast cancer. Read more...0 -
Chemo Brain Can Last for Months After Treatment Ends
January 19, 2017
Chemo brain is a substantial problem for as long as 6 months after treatment is completed. Read more...0 -
Kadcyla Not Better Than Standard of Care as First Treatment for Advanced-Stage, HER2-Positive Disease, but Causes Fewer Side Effects
January 20, 2016
Kadcyla wasn't more effective than Herceptin plus a taxane chemotherapy as the first treatment for advanced-stage, HER2-positive breast cancer, but offered women better quality of life. Read more...0 -
Exercise Helps Ease Aromatase Inhibitor Side Effects
January 26, 2017
Exercise improves body composition in women taking aromatase inhibitors. Read more...0 -
Anxiety Common Among Partners of Young Women Diagnosed With Breast Cancer
January 26, 2017
Research suggests that nearly half of the partners of younger women diagnosed with breast cancer experienced anxiety, sometimes years after the diagnosis. Read more...0 -
Older Women Report Better Cosmetic Results With Lumpectomy and Brachytherapy
January 26, 2017
A study suggests that women 67 and older diagnosed with early-stage breast cancer are more satisfied cosmetically with lumpectomy and brachytherapy compared to other treatment options. Read more...0 -
Does Eating Grilled Meat Affect Survival?
January 27, 2017
A small study seems to suggest that eating grilled, barbecued, and smoked meat may decrease survival after breast cancer. Still, there are questions about the study. Read more...0 -
Brachytherapy Seems to Offer Similar Cosmetic Results, Fewer Late Side Effects Than Whole Breast Radiation
January 31, 2017
For women diagnosed with early-stage disease with a low risk of recurrence, brachytherapy seems to offer the same cosmetic results as whole-breast radiation and causes fewer late side effects. Read more...0 -
Breast Cancer Treatment Causes Severe Side Effects in Many Women
February 3, 2017
Nearly half of women treated for early-stage breast cancer have at least one severe side effect. Read more...0 -
Zometa Every 3 Months Seems as Good as Every Month for Women With Bone Metastases
February 7, 2017
After a year of standard treatment, women with bone metastases can get Zometa every 12 weeks instead of 4 and get the same benefits from the medicine. Read more...0 -
Women Treated for DCIS Live Just as Long as Women With No History of DCIS
February 9, 2017
Research suggests that women treated for DCIS actually live longer than women who haven't been diagnosed with DCIS. Read more...0 -
Care Improving, but Study Finds Variations in Hormonal Therapy Use After Surgery
February 10, 2017
A study suggests that appropriate use of adjuvant hormonal therapy has improved since 2004, but still isn't optimal. Read more...0 -
Women Who Receive False Positive Mammogram Results May Be More Likely to Delay Next Screening
February 13, 2017
Research suggests that women who receive false-positive mammogram results may be more likely to put off their next scheduled mammogram. Read more...0 -
Many Women at High Risk of Genetic Mutation Don't Get Testing
February 14, 2017
A study has found that after being diagnosed with breast cancer, most women want genetic testing but don't get it, and only about half of women at high risk of a genetic mutation are tested. Read more...0 -
Women With Dense Breasts More Likely to Develop Cancer in Opposite Breast
February 14, 2017
A study suggests that women who've been diagnosed with breast cancer and have dense breasts are nearly twice as likely to develop cancer in the opposite breast. Read more...0 -
Worsening Hot Flashes, Other Menopausal Symptoms Cause High-Risk Women to Stop Preventive Hormonal Therapy Early
February 23, 2017
A study suggests that women whose menopausal symptoms get worse after starting preventive Aromasin are more likely to stop taking the preventive medicine early. Read more...0 -
Study Suggests Exercise, Maintaining Healthy Weight Most Important Lifestyle Factors for Reducing Recurrence Risk
February 23, 2017
Exercise has the most potential to reduce the risk of recurrence and improve survival. Read more...0 -
Having More Muscle Mass May Mean Milder Chemotherapy Side Effects
March 3, 2017
Research suggests that women with more muscle mass were likely to have milder chemotherapy side effects than women with less muscle mass. Read more...0 -
Chemotherapy Before Surgery Can Reduce Recurrence Risk in Black Women
March 3, 2017
A study suggests that treating even early-stage breast cancer in black women with chemotherapy before surgery can help reduce their risk of recurrence. Read more...0 -
Exercise, Psychological Therapy Help Ease Cancer-Related Fatigue Better Than Medicine
March 3, 2017
Exercise is the best way to reduce cancer fatigue. Read more...0 -
Online Therapy Seems to Help Improve Sexual Function in Women Treated for Breast Cancer
March 7, 2017
Online therapy can help ease sexual problems related to breast cancer. Read more...0 -
Eating Soy Foods May Offer Benefits for Women Diagnosed With Hormone-Receptor-Negative Disease
March 8, 2017
Eating soy foods may help improve survival in women diagnosed with hormone-receptor-negative breast cancer. Read more...0 -
Adding Experimental Medicine to Xeloda Seems to Improve Metastatic Breast Cancer Outcomes
March 9, 2017
Experimental utidelone added to Xeloda seems to help treat metastatic breast cancer. Read more...0 -
Kisqali Approved by FDA to Treat Hormone-Receptor-Positive Advanced-Stage Disease
March 15, 2017
Kisqali was approved by the FDA on March 13, 2017 to be used in combination with an aromatase inhibitor to treat advanced-stage or metastatic hormone-receptor-positive, HER2-negative breast cancer that hasn't been treated with hormonal therapy yet in postmenopausal women. Read more...0 -
Diabetes Medicine Linked to Better Outcomes in Diabetics With HER2-Positive, Hormone-Receptor-Positive Breast Cancer
March 16, 2017
Diabetic women treated with metformin who have been diagnosed with HER2-positive, hormone-receptor-positive breast cancer have better outcomes, including overall survival, than similar women who were not treated with metformin. Read more...0 -
FDA Updates Warning on Link Between Textured Breast Implants and Rare Cancer
March 22, 2017
Women with breast implants have a very low but increased risk of developing anaplastic large-cell lymphoma compared to women who do not
have breast implants. Read more...0 -
Risk of Heart and Lung Problems From Breast Radiation Higher for Smokers
March 22, 2017
A meta-analysis found that smokers have a much higher risk of dying from lung cancer or a heart attack as a result of radiation therapy for breast cancer. Read more...0 -
Regular Exercise Before Diagnosis Helps Reduce Risk of Treatment-Related Heart Problems
March 23, 2017
Women who did 5 hours of moderate exercise per week before being diagnosed with breast cancer were much less likely to have heart problems after treatment compared to women who exercised for less time. Read more...0 -
Long-Term Results Show 1 Year of Herceptin Best for Lowering Recurrence Risk of Early-Stage, HER2-Positive Disease
March 28, 2017
Eleven years of follow-up information from the HERA trial confirm that 1 year of Herceptin, rather than 2, is best for reducing the risk of recurrence in women diagnosed with HER2-positive, early-stage breast cancer. Read more...0 -
Women Who Have Immediate Autologous Reconstruction Report Being More Satisfied With Breasts, but Have More Pain 1 Year After Surgery
March 31, 2017
A study suggests that 1 year after surgery, women who had immediate autologous reconstruction were more satisfied with their breasts than women who had immediate implant reconstruction. Still, women who had autologous reconstruction had more pain than they did before surgery. Read more...0
